Analyses of Group III Secreted Phospholipase A2 Transgenic Mice Reveal Potential Participation of This Enzyme in Plasma Lipoprotein Modification, Macrophage Foam Cell Formation, and Atherosclerosis
Open Access
- 1 November 2008
- journal article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 283 (48), 33483-33497
- https://doi.org/10.1074/jbc.m804628200
Abstract
No abstract availableThis publication has 82 references indexed in Scilit:
- Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidateBritish Journal of Cancer, 2008
- Importance of group X–secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma modelThe Journal of Experimental Medicine, 2007
- Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesisProceedings of the National Academy of Sciences of the United States of America, 2006
- Inflammation and AtherosclerosisStroke, 2006
- Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptorBiochemical and Biophysical Research Communications, 2005
- Phospholipase A2 enzymesProstaglandins & Other Lipid Mediators, 2002
- Role of Group II Secretory Phospholipase A2in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959